Drugs that reduce blood pressure by lowering blood sugar levels are often touted as safe and effective.
But a new study finds that a new class of drugs called vasopressors, which also lower blood sugar, may be more harmful than they are helpful.
In fact, the study found that the drugs may increase the risk of developing hypertension and diabetes.
What is vasopressor drugs?
Vasopressers are drugs that lower the level of the hormone epinephrine, which is important for blood pressure control.
Epinephrine is released when blood pressure is low.
Vasopressor drugs include statins, angiotensin-converting enzyme inhibitors, and beta blockers.
Most vasopressive drugs are approved for use by primary care doctors and are given to people who are overweight or obese.
But they can also be prescribed to people with diabetes or heart disease.
The study, published March 3 in the journal Hypertension, looked at blood pressure in nearly 600,000 people who had blood pressure readings between 140 and 180 mmHg and were prescribed statins and angiotENSIN inhibitors.
It found that those with high blood pressure were at greater risk of having hypertension and being at higher risk for developing diabetes.
Researchers say vasopression drugs, like statins or angiotENIs, are not as effective as statins as they are for lowering blood pressure.
The authors say that the study doesn’t suggest that vasopresses are necessarily more dangerous than statins.
The reason that statins aren’t more effective than vasopresis in lowering blood levels is because statins have a longer half-life than vasopsis, the researchers write.
The researchers also point out that the people who took statins had lower LDL cholesterol, which may lower the risk for cardiovascular disease.
But the researchers caution that the results of this study should not be taken as an endorsement of vasopreventive therapy, or as a way to make people stop taking statins altogether.
In general, statins can be useful for managing high blood cholesterol, but the benefits of vasostatin outweigh the risk, they write.
If you’re having trouble reading this story, click here.
Read more from The Washington Post: